Top 3 Reasons Behind Eli Lilly’s $1.3 Billion Bid for Verve Therapeutics Breaking News Corporate News Top 3 Reasons Behind Eli Lilly’s $1.3 Billion Bid for Verve Therapeutics James B. June 21, 2025 Eli Lilly and Company (NYSE: LLY) has announced a definitive agreement to acquire Verve Therapeutics (NASDAQ: VERV),... Read More Read more about Top 3 Reasons Behind Eli Lilly’s $1.3 Billion Bid for Verve Therapeutics
